Nurosym’s device is equally user-friendly, making use of a similar device to stimulate the vagus nerve—which runs between the ...

By Gerry Everding SHARE Marco Pignatelli, MD, an assistant professor of psychiatry at Washington University School of ...

Preliminary results from the first study to use a chronic stress and depression mouse model to investigate the impacts of cholesterol-lowering treatment have provided insight into how depression and ...

Neuroscience continues to represent a challenging area for drug developers. Even with skyrocketing rates of neuropsychiatric diseases like anxiety disorders and depression, particularly during the ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and increased risk of depression and suicidal ideation, especially in people with low ...

Neurostimulation as a ‘cure’ for depression: is it possible to biohack your brain? - IN FOCUS: Would you try an ...

Neuroscience is a multidisciplinary science that is concerned with the study of the structure and function of the nervous system. It encompasses the evolution, development, cellular and molecular ...

Previous research has suggested that stress or depression, or both, contribute to troubled sleep or heavy drinking, said first study author Justin Verlinden, a cognitive neuroscience PhD student at ...

The innovative advance could shift treatment from response to prevention, and redefine how we think about this common maternal condition.

A new study published in The Journal of Immunology found that a high-salt diet (HSD) induces depression-like symptoms in mice by driving the production of a protein called IL-17A. This protein has ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...